Editorial: Advances in Understanding NeuroHIV Associated Changes in Neuroimmune Communication in the Combined Anti-retroviral Therapy (cART) Era

Editorial: Advances in Understanding NeuroHIV Associated Changes in Neuroimmune Communication in the Combined Anti-retroviral Therapy (cART) Era

Bibliographic Details
Main Authors:	Peter J. Gaskill, Jerel Adam Fields, Dianne T. Langford, Kelly L. Stauch, Dionna W. Williams
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Neurology
Subjects:	neuroAIDS neuroimmunity neuropathogenesis neurotransmission CART neuroHIV
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2021.763448/full

Similar Items

Co-receptor signaling in the pathogenesis of neuroHIV
by: E. A. Nickoloff-Bybel, et al.
Published: (2021-08-01)

Connexin43 Containing Gap Junction Channels Facilitate HIV Bystander Toxicity: Implications in NeuroHIV
by: Shaily Malik, et al.
Published: (2017-12-01)

Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV
by: Stephanie M. Matt, et al.
Published: (2021-05-01)

Astrocytes, HIV and the Glymphatic System: A Disease of Disrupted Waste Management?
by: Caitlin Tice, et al.
Published: (2020-09-01)

Contribution of CNS cells in NeuroAIDS
by: Ashish Swarup Verma, et al.
Published: (2010-01-01)

Characterization of monocyte subsets through the course of AIDS pathogenesis and correlations with the development of SIV-Encephalitis
by: Shin, Hyunjin
Published: (2010)

CXCL12-induced rescue of cortical dendritic spines and cognitive flexibility
by: Lindsay K Festa, et al.
Published: (2020-01-01)

The Glutamate System as a Crucial Regulator of CNS Toxicity and Survival of HIV Reservoirs
by: Anna Maria Gorska, et al.
Published: (2020-06-01)

Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS
by: Anupam Sarma, et al.
Published: (2020-12-01)

Advances in SIV/SHIV Non-Human Primate Models of NeuroAIDS
by: Sonia Moretti, et al.
Published: (2021-08-01)

Boosting the Brain Delivery of Atazanavir through Nanostructured Lipid Carrier-Based Approach for Mitigating NeuroAIDS
by: Saif Ahmad Khan, et al.
Published: (2020-11-01)

Molecular Pathology of Neuro-AIDS (CNS-HIV)
by: Eliezer Masliah, et al.
Published: (2009-03-01)

Gray matter volumes discriminate cognitively impaired and unimpaired people with HIV
by: Mikki Schantell, et al.
Published: (2021-01-01)

Challenging new targets for CNS-HIV infection
by: Mario eGanau, et al.
Published: (2012-03-01)

HIV-1 Tat alters neuronal intrinsic excitability
by: Walter Francesconi, et al.
Published: (2018-05-01)

Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”
by: Guoku Hu, et al.
Published: (2017-12-01)

Methamphetamine Increases the Proportion of SIV-Infected Microglia/Macrophages, Alters Metabolic Pathways, and Elevates Cell Death Pathways: A Single-Cell Analysis
by: Meng Niu, et al.
Published: (2020-11-01)

Phenotypic changes in the brain of SIV-infected macaques exposed to methamphetamine parallel macrophage activation patterns induced by the common gamma-chain cytokine system
by: Nikki eBortell, et al.
Published: (2015-09-01)

The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
by: Slava eRom, et al.
Published: (2015-08-01)

Monocyte / Macrophage Traffic Plays an Essential Role in HIV and SIV Pathogenesis
by: Campbell, Jennifer Helen
Published: (2014)

Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain
by: Yun K. Hahn, et al.
Published: (2016-08-01)

NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report
by: Baharin, J, et al.
Published: (2021)

HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: Protection by rSV40 delivery of antioxidant enzymes
by: Jean-Pierre Louboutin, et al.
Published: (2009-06-01)

Neuro-Optometry, Neuro-Optometrist, and Neuro-Optometric Rehabilitative Implications
by: Ali Nouraeinejad
Published: (2019-01-01)

Fractalkine/CX<sub>3</sub>CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death
by: Suzuki Masami, et al.
Published: (2011-11-01)

Red flags in neuro-ophthalmology
by: Olufunmilola Ogun
Published: (2017-03-01)

A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates
by: Sarah Kim, et al.
Published: (2018-10-01)

Dos casos de neuro-retinitis
by: Alfonso Tribin Piedrahita
Published: (1948-03-01)

HIV and illicit drugs of abuse
by: Venkata Subba Rao Atluri
Published: (2016-03-01)

Infection-Associated Mechanisms of Neuro-Inflammation and Neuro-Immune Crosstalk in Chronic Respiratory Diseases
by: Belinda Camp, et al.
Published: (2021-05-01)

Music Therapy Advances in Neuro-disability - Innovations in Research and Practice: Summary Report and Reflections on a Two-Day International Conference
by: Julian Winn O'Kelly, et al.
Published: (2014-02-01)

Implications of Neuroimmunity in Alzheimer’s Disease: A Review
by: Katriel Lee
Published: (2017-10-01)

Two cases of possible neuro-Sweet disease with meningoencephalitis as the initial manifestation
by: Go Makimoto, et al.
Published: (2012-02-01)

Novelties in neuro-ophthalmology
by: D. Costin
Published: (2011-03-01)

Romanian neuro-ophthalmology
by: Tatiana Rosca
Published: (2007-08-01)

Neuro-fuzzy modeling in bankruptcy prediction
by: Vlachos D., et al.
Published: (2003-01-01)

Editorial: Direct and Indirect Interactions of HIV With Host Cells
by: Tetsuo Tsukamoto, et al.
Published: (2021-10-01)

NEURO-HUMORAL DISBALANCE IN CHRONIC HEART FAILURE: CLASSIC AND MODERN PERSPECTIVES
by: A. G. Obrezan, et al.
Published: (2017-10-01)

Neuroimmune Regulation of Surgery-Associated Metastases
by: Michael R. Shurin, et al.
Published: (2021-02-01)

DEVELOPMENT OF ANTAGONISTS TARGETING CHEMOKINE RECEPTOR CCR5 AND THE CHEMOKINE RECEPTOR CCR5 – MU OPIOID RECEPTOR HETERODIMER
by: Arnatt, Christopher Kent
Published: (2013)